The review looks at the presence of authorised and unauthorised pharmacologically active substances and their residues in food. The data in the 2023 report came from the EU Member States[1], plus Iceland and Norway.
In 2023, the percentage of non-compliant samples was 0.11% (602 of 548,194 samples) overall.
This report is the first to feature a revised division of the samples under three plans:
- National risk-based control plan for production in the Member States – 0.15% non-compliance
- National randomised surveillance plan – 0.29% non-compliance
- National risk-based control plan for third-country imports – 0.23% non-compliance.
EFSA’s report supports risk managers in the European Commission and in Member States to evaluate the effectiveness of control plans on pharmacologically active substances and their residues in limiting the presence of these substance groups in the EU food chain. It also helps determine follow up measures to further reduce non-compliance in subsequent years.
Explore the results in greater detail using our interactive dashboard and a data visualisation.
- Report for 2023 on the results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products
O artigo foi publicado originalmente em EFSA.
